The global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection market size was valued at US$ 26.1 million in 2024 and is forecast to a readjusted size of USD 39.8 million by 2031 with a CAGR of 5.0% during review period.
Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection is a biopharmaceutical product developed based on RNA technology, specifically designed to activate or regulate the patient's immune system to fight tumor cells. This type of drug enhances the body's ability to recognize and eliminate cancer cells through a specific mechanism, is suitable for the treatment of various types of cancer, and may be used in combination with other treatments to improve the overall efficacy and quality of life of patients.
This report is a detailed and comprehensive analysis for global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Northeast Pharmaceutical Group, Zhejiang Fengan Biopharmaceutical Co., Ltd., Anhui City Pharmaceutical Co., Ltd., Hebei Zhitong Biopharmaceutical Co., Ltd., Shenyang Everbright Pharmaceutical Co., Ltd., Renhe Xidelong Pharmaceutical Co., Ltd., Jilin Huinan Changlong Biochemical Pharmaceutical Co., Ltd., Wuhan Hualong Biopharmaceutical Co., Ltd., Tianda Pharmaceutical (Yunnan) Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Single-dose Packaging
Multiple-dose Packaging
麻豆原创 segment by Application
Hospital
Clinic
Other
Major players covered
Northeast Pharmaceutical Group
Zhejiang Fengan Biopharmaceutical Co., Ltd.
Anhui City Pharmaceutical Co., Ltd.
Hebei Zhitong Biopharmaceutical Co., Ltd.
Shenyang Everbright Pharmaceutical Co., Ltd.
Renhe Xidelong Pharmaceutical Co., Ltd.
Jilin Huinan Changlong Biochemical Pharmaceutical Co., Ltd.
Wuhan Hualong Biopharmaceutical Co., Ltd.
Tianda Pharmaceutical (Yunnan) Co., Ltd.
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection, with price, sales quantity, revenue, and global market share of Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection from 2020 to 2025.
Chapter 3, the Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection.
Chapter 14 and 15, to describe Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Single-dose Packaging
1.3.3 Multiple-dose Packaging
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection 麻豆原创 Size & Forecast
1.5.1 Global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity (2020-2031)
1.5.3 Global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Northeast Pharmaceutical Group
2.1.1 Northeast Pharmaceutical Group Details
2.1.2 Northeast Pharmaceutical Group Major Business
2.1.3 Northeast Pharmaceutical Group Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Product and Services
2.1.4 Northeast Pharmaceutical Group Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Northeast Pharmaceutical Group Recent Developments/Updates
2.2 Zhejiang Fengan Biopharmaceutical Co., Ltd.
2.2.1 Zhejiang Fengan Biopharmaceutical Co., Ltd. Details
2.2.2 Zhejiang Fengan Biopharmaceutical Co., Ltd. Major Business
2.2.3 Zhejiang Fengan Biopharmaceutical Co., Ltd. Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Product and Services
2.2.4 Zhejiang Fengan Biopharmaceutical Co., Ltd. Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Zhejiang Fengan Biopharmaceutical Co., Ltd. Recent Developments/Updates
2.3 Anhui City Pharmaceutical Co., Ltd.
2.3.1 Anhui City Pharmaceutical Co., Ltd. Details
2.3.2 Anhui City Pharmaceutical Co., Ltd. Major Business
2.3.3 Anhui City Pharmaceutical Co., Ltd. Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Product and Services
2.3.4 Anhui City Pharmaceutical Co., Ltd. Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Anhui City Pharmaceutical Co., Ltd. Recent Developments/Updates
2.4 Hebei Zhitong Biopharmaceutical Co., Ltd.
2.4.1 Hebei Zhitong Biopharmaceutical Co., Ltd. Details
2.4.2 Hebei Zhitong Biopharmaceutical Co., Ltd. Major Business
2.4.3 Hebei Zhitong Biopharmaceutical Co., Ltd. Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Product and Services
2.4.4 Hebei Zhitong Biopharmaceutical Co., Ltd. Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Hebei Zhitong Biopharmaceutical Co., Ltd. Recent Developments/Updates
2.5 Shenyang Everbright Pharmaceutical Co., Ltd.
2.5.1 Shenyang Everbright Pharmaceutical Co., Ltd. Details
2.5.2 Shenyang Everbright Pharmaceutical Co., Ltd. Major Business
2.5.3 Shenyang Everbright Pharmaceutical Co., Ltd. Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Product and Services
2.5.4 Shenyang Everbright Pharmaceutical Co., Ltd. Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Shenyang Everbright Pharmaceutical Co., Ltd. Recent Developments/Updates
2.6 Renhe Xidelong Pharmaceutical Co., Ltd.
2.6.1 Renhe Xidelong Pharmaceutical Co., Ltd. Details
2.6.2 Renhe Xidelong Pharmaceutical Co., Ltd. Major Business
2.6.3 Renhe Xidelong Pharmaceutical Co., Ltd. Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Product and Services
2.6.4 Renhe Xidelong Pharmaceutical Co., Ltd. Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Renhe Xidelong Pharmaceutical Co., Ltd. Recent Developments/Updates
2.7 Jilin Huinan Changlong Biochemical Pharmaceutical Co., Ltd.
2.7.1 Jilin Huinan Changlong Biochemical Pharmaceutical Co., Ltd. Details
2.7.2 Jilin Huinan Changlong Biochemical Pharmaceutical Co., Ltd. Major Business
2.7.3 Jilin Huinan Changlong Biochemical Pharmaceutical Co., Ltd. Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Product and Services
2.7.4 Jilin Huinan Changlong Biochemical Pharmaceutical Co., Ltd. Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Jilin Huinan Changlong Biochemical Pharmaceutical Co., Ltd. Recent Developments/Updates
2.8 Wuhan Hualong Biopharmaceutical Co., Ltd.
2.8.1 Wuhan Hualong Biopharmaceutical Co., Ltd. Details
2.8.2 Wuhan Hualong Biopharmaceutical Co., Ltd. Major Business
2.8.3 Wuhan Hualong Biopharmaceutical Co., Ltd. Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Product and Services
2.8.4 Wuhan Hualong Biopharmaceutical Co., Ltd. Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Wuhan Hualong Biopharmaceutical Co., Ltd. Recent Developments/Updates
2.9 Tianda Pharmaceutical (Yunnan) Co., Ltd.
2.9.1 Tianda Pharmaceutical (Yunnan) Co., Ltd. Details
2.9.2 Tianda Pharmaceutical (Yunnan) Co., Ltd. Major Business
2.9.3 Tianda Pharmaceutical (Yunnan) Co., Ltd. Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Product and Services
2.9.4 Tianda Pharmaceutical (Yunnan) Co., Ltd. Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Tianda Pharmaceutical (Yunnan) Co., Ltd. Recent Developments/Updates
3 Competitive Environment: Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection by Manufacturer
3.1 Global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity by Manufacturer (2020-2025)
3.2 Global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Revenue by Manufacturer (2020-2025)
3.3 Global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Manufacturer 麻豆原创 Share in 2024
3.5 Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection 麻豆原创: Overall Company Footprint Analysis
3.5.1 Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection 麻豆原创: Region Footprint
3.5.2 Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection 麻豆原创: Company Product Type Footprint
3.5.3 Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection 麻豆原创 Size by Region
4.1.1 Global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity by Region (2020-2031)
4.1.2 Global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Consumption Value by Region (2020-2031)
4.1.3 Global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Average Price by Region (2020-2031)
4.2 North America Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Consumption Value (2020-2031)
4.3 Europe Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Consumption Value (2020-2031)
4.4 Asia-Pacific Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Consumption Value (2020-2031)
4.5 South America Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Consumption Value (2020-2031)
4.6 Middle East & Africa Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity by Type (2020-2031)
5.2 Global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Consumption Value by Type (2020-2031)
5.3 Global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity by Application (2020-2031)
6.2 Global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Consumption Value by Application (2020-2031)
6.3 Global Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Average Price by Application (2020-2031)
7 North America
7.1 North America Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity by Type (2020-2031)
7.2 North America Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity by Application (2020-2031)
7.3 North America Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection 麻豆原创 Size by Country
7.3.1 North America Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity by Country (2020-2031)
7.3.2 North America Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity by Type (2020-2031)
8.2 Europe Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity by Application (2020-2031)
8.3 Europe Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection 麻豆原创 Size by Country
8.3.1 Europe Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity by Country (2020-2031)
8.3.2 Europe Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection 麻豆原创 Size by Region
9.3.1 Asia-Pacific Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity by Type (2020-2031)
10.2 South America Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity by Application (2020-2031)
10.3 South America Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection 麻豆原创 Size by Country
10.3.1 South America Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity by Country (2020-2031)
10.3.2 South America Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection 麻豆原创 Size by Country
11.3.1 Middle East & Africa Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection 麻豆原创 Drivers
12.2 Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection 麻豆原创 Restraints
12.3 Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection
13.3 Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Typical Distributors
14.3 Immunoglobulin Ribonucleic Acid of Anti Cancer for Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Northeast Pharmaceutical Group
Zhejiang Fengan Biopharmaceutical Co., Ltd.
Anhui City Pharmaceutical Co., Ltd.
Hebei Zhitong Biopharmaceutical Co., Ltd.
Shenyang Everbright Pharmaceutical Co., Ltd.
Renhe Xidelong Pharmaceutical Co., Ltd.
Jilin Huinan Changlong Biochemical Pharmaceutical Co., Ltd.
Wuhan Hualong Biopharmaceutical Co., Ltd.
Tianda Pharmaceutical (Yunnan) Co., Ltd.
听
听
*If Applicable.
